The U.S. Food and Drug Administration reported receiving several adverse events following the administration of an affected lot “potentially subpotent” L-Citrulline.
L-Citrulline is used to treat urea cycle disorders, and subpotent levels of L-Citrulline can cause potentially life-threatening high levels of ammonia, according to an FDA report.
More Articles on Recalls:
Ben Venue Laboratories Recalls 10% Acetylcysteine Solution
FDA Recalls Covidien’s Puritan Bennett 840 Ventilator
FDA Recalls Faulty Antimicrobial Hospital Safety Showers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
